Technology report :
Technology report : the cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis /
Andreas Maetzel, Murray Krahn, Gary Naglie.
- Ottawa, Can. : CCOHTA, 2002.
- 39 p.
- Technology report ; .
1-894620-35-6
Artritis Reumatoide --Terapia --Rehabilitación.
617.356 / T258c
1-894620-35-6
Artritis Reumatoide --Terapia --Rehabilitación.
617.356 / T258c